Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

BACKGROUND: Intratumoral BCG therapy, one of the earliest immunotherapies, can lead to infiltration of immune cells into a treated tumor. However, an increase in the number of BCG-induced tumor-specific T cells in the tumor microenvironment could lead to enhanced therapeutic effects. METHODS: Here,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Ylösmäki, Erkko, Fusciello, Manlio, Martins, Beatriz, Feola, Sara, Hamdan, Firas, Chiaro, Jacopo, Ylösmäki, Leena, Vaughan, Matthew J, Viitala, Tapani, Kulkarni, Prasad S, Cerullo, Vincenzo
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2021
Teme:
Oncolytic and Local Immunotherapy
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286790/
https://ncbi.nlm.nih.gov/pubmed/34266884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002707
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki